Chen, Jiakai
Wang, Danni
Wang, Bing
Zhou, Chengwei
Ding, Chuan-Fan
Yan, Yinghua
Funding for this research was provided by:
the National K & D program of China (2023YFF0613402)
Article History
Received: 2 April 2024
Revised: 31 May 2024
Accepted: 3 June 2024
First Online: 14 June 2024
Declarations
:
: The serum of normal control and breast cancer patients was obtained from the Affiliated Hospital of Medical School, Ningbo University, with the approval from its Ethics Committee (KS20227002).
: All authors approved the final version of the manuscript.
: The authors declare no competing interests.